After two years work at 4 oC, diffracting crystals of this GTPase activating enzyme could finally be produced and B.I.F. fellow Dr. Oliver Daumke could determine the protein's unusual three-dimensional structure and reaction mechanism. His results were published in Nature 429, pp. 197-201, in 2004.
The Schlossmühle in Heidesheim
The Schlossmühle in Heidesheim, Germany, where the Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine, conducts its business.
